If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

As a neuropharmacologist I have contributed to the understanding of brain circuitry, particularly the involvement of the neurotransmitter dopamine on regulating brain function using rodent models. In the past few years I have discovered neurotransmitter/neurochemical interactions that regulate behaviours associated with drug abuse and dietary intake, such as: reward, addiction, psychoses, depression, anxiety and memory function. I am a member of the Centre for Emotional Health, Frontiers in Biomolecular Research Centre and the Centre for Nanoscale BioPhotonics (Australian Research Council Centre of Excellence).  

Research interests

I am particularly interested in understanding the neurobiology of:

  • drug (methamphetamine) addiction
  • drug (methamphetamine)-induced psychosis
  • alcopop addiction
  • anxiety
  • oxytocin as a therapeutic
  • cannabinoids as therapeutics
  • brain circuitry - dopamine, glutamate, GABA

Research student supervision

I supervise honours, Clinical Masters (Neuropsychology), Masters of Research and PhD candidates studying the impact of drug abuse on mental health for pharmacotherapeutic discovery.

Teaching

  • PSYC104 First year Psychology (Lecturer)
  • PSY236 Biopsychology & Learning (Lecturer, co-convenor)
  • PSY354 Clinical and Experimental Neuroscience (Convenor, Lecturer)
  • PSYN841/987 Clinical Psychopharmacology (Convenor, Lecturer)
  • MRES700 Research Communications (Convenor, Lecturer)
  • MEDI303 Neuroscience 2 (Guest Lecturer)

Research engagement

Research affiliations:

  • Centre for Emotional Health
  • Center for Atypical Neurodevelopment
  • Frontiers in Biomolecular Research Centre
  • Centre for Nanoscale BioPhotonics (ARC, AI)
  • Australasian Neuroscience Society
  • British Society of Neuroendocrinology
  • Kinoxis Pharmaceuticals
  • Lambert Initiative

Community engagement

  • Panel member for the National Health and Medical Research Council
  • Associate Dean, Higher Degree Research for the Faculty of Human Sciences
  • Frequent reviewer for neuroscience and pharmacology journals

Fingerprint Dive into the research topics where Jennifer Cornish is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Methamphetamine Medicine & Life Sciences
N-Methyl-3,4-methylenedioxyamphetamine Medicine & Life Sciences
Oxytocin Medicine & Life Sciences
Self Administration Medicine & Life Sciences
Nucleus Accumbens Medicine & Life Sciences
Dopamine Medicine & Life Sciences
Prefrontal Cortex Medicine & Life Sciences
Cocaine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2006 2019

Research Outputs 1994 2019

A neuroethics framework for the Australian Brain Initiative

Australian Brain Alliance, Chakli, K. & Hatherly, C., 6 Feb 2019, In : Neuron. 101, 3, p. 365-369 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Brain
Industry
Methamphetamine
Nucleus Accumbens
Oxytocin
Recurrence
Therapeutics

A comparison of methamphetamine-induced psychosis and schizophrenia: a review of positive, negative, and cognitive symptomatology

Wearne, T. A. & Cornish, J. L., 10 Oct 2018, In : Frontiers in Psychiatry. 9, OCT, p. 1-21 21 p., 491.

Research output: Contribution to journalReview articleResearchpeer-review

Open Access
File
Methamphetamine
Psychotic Disorders
Schizophrenia
Hallucinations
Behavioral Symptoms

Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats

Hay, G. L., Baracz, S. J., Everett, N. A., Roberts, J., Costa, P. A., Arnold, J. C., McGregor, I. S. & Cornish, J. L., Dec 2018, In : Journal of psychopharmacology (Oxford, England). 32, 12, p. 1369-1378 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Cannabidiol
Methamphetamine
Motivation
Recurrence
Reinforcement Schedule